JAZZ
Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc (JAZZ) has 10 SEC Form 4 filings (26 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jul 6, 2026.
Insiders have net sold $13.5M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Renee D. Gala
- Employees:2,890
- HQ:Dublin, IE
- IPO:2007-06-01
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$13.5M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$14.9B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
COZADD BRUCE CFirst filing | Director | Sale | 6,000 | $1.4M | Jul 6 | SEC ↗ |
Smith Mark DouglasFirst filing | Director | Sale | 1,157 | $267K | Jun 17 | SEC ↗ |
Winningham Rick EFirst filing | Director | Sale | 2,741 | $662K | May 27 | SEC ↗ |
McSharry Heather AnnFirst filing | Director | Sale | 2,000 | $482K | May 27 | SEC ↗ |
Patil Neena MFirst filing | EVP & Chief Legal Officer | Sale | 55,600 | $10.7M | Mar 2 | SEC ↗ |
Related companies
Jazz Pharmaceuticals plc is in the Healthcare sector.